You are here
Global Medical Marijuana Market Forecast to 2024: Trend of Producing Edible Products with Cannabis Gaining Momentum
DUBLIN, March 22, 2019 /PRNewswire/ -- The "Medical Marijuana Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
The major factors for the growth of the medical marijuana market include the increasing number of countries legalizing the use of medical marijuana, trend of producing edible products with cannabis, and favorable reimbursement environment and government support in selected countries, which are expected to experience a boost over the forecast period.
Each year, the legal use of cannabis for medical and recreational purposes is steadily growing, but it varies across countries, based on the possession, distribution, cultivation, and medical indications for its consumption. Therefore, over the forecast period, the change is expected to be slow, but more legal consumption of cannabis is expected in the developed market, which is expected to largely drive the market studied.
Currently, there is also an increasing use of marijuana as a functional food, with purported health benefits far outnumbering what consumers can get from kale, turmeric, or kombucha. With the new generation growing up in the United States, where cannabis is legal, new products are found rapidly entering the market, which is expected to grow rapidly over the forecast period.
The growth of the market is also attributed to factors, like the trends of producing edible products with cannabis in selected countries. Therefore marijuana is expected to be included in the 2018 food trends, as the drug and its ingredients have been gradually making their way into the public market.
Doctors also prescribe medical marijuana to treat muscle spasms caused by multiple sclerosis, nausea, poor appetite, and weight loss, caused by chronic illness, such as HIV, nerve pain, and Crohn's disease. Thus, with the increasing applications, there is a huge opportunity for marijuana for medicinal purposes.
Scope of the Report
As per the scope of the report, medical marijuana refers to the whole, unprocessed marijuana plant, or its basic extracts, for the treatment of several diseases and other related symptoms. Scientific studies show that chemical cannabinoids could help treat a range of diseases and symptoms, which has attracted several biopharmaceutical companies, globally, over the past two decades. The market is expected to witness significant growth, owing to legalization in several countries and high demand for both medical and recreational purposes.
Key Market Trends
Chronic Pain is the Segment under Application that is Expected to Experience the Fastest Growth during the Forecast Period
There are many studies that have shown that medical cannabis is found to be an effective method for the treatment of chronic pain, and that it is far safer than many other options. It is an affordable, natural alternative that lacks side effects and is traditionally used to treat chronic pain. There are also several ongoing researches on medical marijuana for the treatment of chronic pain, which is expected to directly impact the growth of the market.
Marijuana is also being used for the treatment of arthritis, as it has the potential to reduce inflammation, as well reduce pain. There is also an increasing research on medical marijuana for the treatment of cancer and commercially available cannabinoids, which are approved drugs for chemotherapy, and which are likely to augment the growth of the market. Marijuana, being an effective treatment for neuropathic pain, is expected to further rise over the forecast timeframe.
North America Accounted for the Largest Share in the Global Market
North America holds the major share in the medical marijuana market, and is expected to show a similar trend over the forecast period, without significant fluctuations. The surging pace of cannabis legalization in the United States is one of the key factors contributing to its increased demand. There are also many marijuana programs in the United States that have accelerated, and most of the states have started to approach medical marijuana from the perspective of good public health.
The market studied is dominated by a few major players, and currently, only in a few countries, the use of cannabis is legal. Because of this, several companies were not able to launch their products.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Countries Legalizing the Use of Medical Marijuana
4.2.2 Trend of Producing Edible Products with Cannabis
4.2.3 Favorable Reimbursement Environment and Government Support in Certain Countries
4.3 Market Restraints
4.3.1 Lack of Awareness about the Dosage and Medicinal Properties of Marijuana
4.3.2 Social Stigma Related to Cannabis Use
4.4 Porter's Five Forces Analysis
5 Market Segmentation
5.1 By Application
5.1.1 Chronic Pain
5.1.5 Other Applications
5.2.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.2.4 Middle East & Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East & Africa
5.2.5 South America
18.104.22.168 Rest of South America
6 Competitive Landscape
6.1 Company Profiles
6.1.1 Canopy Growth
6.1.2 Lexaria Corp.
6.1.3 United Cannabis Corporation
6.1.4 Aurora Cannabis
6.1.5 Cannabis Sativa Inc.
6.1.6 Cara Therapeutics Inc.
6.1.7 GW Pharmaceuticals PLC
6.1.8 LivWell Enlightened Health LLC
6.1.9 Aphria Inc
6.1.10 Medical Marijuana Inc.
6.1.11 Lexaria Corporation
6.1.12 United Cannabis Corporation
6.1.13 Aurora Cannabis
6.1.14 Cannabis Sativa Inc.
7 Market Opportunities and Future Trends
For more information about this report visit https://www.researchandmarkets.com/research/zn8w83/global_medical?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets